| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A long-term follow-up of primary hepatic mucosa-associated lymphoid tissue lymphoma
|
Chen, Yang-Yuan
|
|
|
52 |
11 |
p. 1365-1366
|
artikel
|
| 2 |
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B
|
Kim, Kyung Hyun
|
|
|
52 |
11 |
p. 1338-1345
|
artikel
|
| 3 |
Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
|
Prentice, Ralley E.
|
|
|
52 |
11 |
p. 1250-1251
|
artikel
|
| 4 |
Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease
|
Macaluso, Fabio Salvatore
|
|
|
52 |
11 |
p. 1304-1309
|
artikel
|
| 5 |
Can red blood cell distribution width predict the severity and prognosis of hepatitis B virus–related diseases?
|
Chen, Yongxin
|
|
|
52 |
11 |
p. 1372
|
artikel
|
| 6 |
Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?
|
Oliva, Salvatore
|
|
|
52 |
11 |
p. 1219-1221
|
artikel
|
| 7 |
Clinical characteristics and long-term health in celiac disease patients diagnosed in early childhood: Large cohort study
|
Koskimaa, Sara
|
|
|
52 |
11 |
p. 1315-1322
|
artikel
|
| 8 |
Comment on “Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma”
|
Binay Safer, Vildan
|
|
|
52 |
11 |
p. 1374-1375
|
artikel
|
| 9 |
Comment to “Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease”
|
Barreiro de Acosta, Manuel
|
|
|
52 |
11 |
p. 1302-1303
|
artikel
|
| 10 |
COVID-19 and intestinal inflammation: Role of fecal calprotectin
|
Ojetti, Veronica
|
|
|
52 |
11 |
p. 1231-1233
|
artikel
|
| 11 |
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data
|
Macaluso, Fabio Salvatore
|
|
|
52 |
11 |
p. 1222-1227
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
52 |
11 |
p. i-ii
|
artikel
|
| 13 |
Endoscopic ultrasound-guided gastro-enteric anastomosis: A systematic review and meta-analysis
|
Antonelli, Giulio
|
|
|
52 |
11 |
p. 1294-1301
|
artikel
|
| 14 |
Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practice
|
Armuzzi, Alessandro
|
|
|
52 |
11 |
p. 1259-1265
|
artikel
|
| 15 |
Expression of DCP1a in gastric cancer and its biological function and mechanism in chemotherapy resistance in gastric cancer cells
|
Ruan, Tuo
|
|
|
52 |
11 |
p. 1351-1358
|
artikel
|
| 16 |
Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
|
Younes, Cherradi
|
|
|
52 |
11 |
p. 1230
|
artikel
|
| 17 |
Follicular dendritic cell sarcoma presenting as duodenal tumor
|
Liu, Fei
|
|
|
52 |
11 |
p. 1367-1369
|
artikel
|
| 18 |
Foreign body and caustic ingestions in children: A clinical practice guideline
|
Oliva, Salvatore
|
|
|
52 |
11 |
p. 1266-1281
|
artikel
|
| 19 |
Improving the screening of precancerous anal lesions in high-risk subjects with normal cytology: A longitudinal cohort study using simple tests
|
Moreau, Johanna
|
|
|
52 |
11 |
p. 1359-1364
|
artikel
|
| 20 |
In memory of Vittorio Ricci, scientist and friend
|
Romano, Marco
|
|
|
52 |
11 |
p. 1377-1378
|
artikel
|
| 21 |
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging
|
|
|
|
52 |
11 |
p. 1282-1293
|
artikel
|
| 22 |
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study
|
Lambin, Thomas
|
|
|
52 |
11 |
p. 1323-1330
|
artikel
|
| 23 |
Low frequency of COVID-19 in inflammatory bowel diseases
|
Marafini, Irene
|
|
|
52 |
11 |
p. 1234-1235
|
artikel
|
| 24 |
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era
|
Nardone, Olga Maria
|
|
|
52 |
11 |
p. 1236-1237
|
artikel
|
| 25 |
Onset of ulcerative colitis during SARS-CoV-2 infection
|
Calabrese, Emma
|
|
|
52 |
11 |
p. 1228-1229
|
artikel
|
| 26 |
Painless chronic pancreatitis
|
Amodio, Antonio
|
|
|
52 |
11 |
p. 1333-1337
|
artikel
|
| 27 |
Reorganization of the endoscopic activity of Cancer Institutes during phase II of the Covid-19 emergency
|
Fiori, Giancarla
|
|
|
52 |
11 |
p. 1346-1350
|
artikel
|
| 28 |
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
|
Zingone, Fabiana
|
|
|
52 |
11 |
p. 1252-1253
|
artikel
|
| 29 |
Reply to comment: “Can red blood cell distribution width predict the severity and prognosis of hepatitis B virus–related diseases?”
|
Huang, Rui
|
|
|
52 |
11 |
p. 1373
|
artikel
|
| 30 |
Reply to comment on “Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma"
|
Benadon, Bethsabée
|
|
|
52 |
11 |
p. 1376
|
artikel
|
| 31 |
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre
|
Zingone, Fabiana
|
|
|
52 |
11 |
p. 1248-1249
|
artikel
|
| 32 |
Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection
|
Mayer, Pierre
|
|
|
52 |
11 |
p. 1257-1258
|
artikel
|
| 33 |
SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?
|
Bardasi, Giulia
|
|
|
52 |
11 |
p. 1244-1245
|
artikel
|
| 34 |
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns
|
Festa, Stefano
|
|
|
52 |
11 |
p. 1246-1247
|
artikel
|
| 35 |
Seronegative autoimmune atrophic gastritis is more common in elderly patients
|
Conti, Laura
|
|
|
52 |
11 |
p. 1310-1314
|
artikel
|
| 36 |
Shedding light on painless chronic pancreatitis
|
Hollenbach, Marcus
|
|
|
52 |
11 |
p. 1331-1332
|
artikel
|
| 37 |
Small bowel obstruction caused by infant compression during pregnancy
|
Hsu, Po-Ke
|
|
|
52 |
11 |
p. 1370-1371
|
artikel
|
| 38 |
Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial
|
Jena, Anuraag
|
|
|
52 |
11 |
p. 1254-1256
|
artikel
|
| 39 |
The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”
|
Pugliese, Daniela
|
|
|
52 |
11 |
p. 1238-1240
|
artikel
|
| 40 |
Urgent surgery for inflammatory bowel diseases during the COVID-19 outbreak in a high incidence area - Experience from a high-volume centre
|
Botti, Fiorenzo
|
|
|
52 |
11 |
p. 1241-1243
|
artikel
|
Tijdschrift beschrijving